In patients with severe asthma with eosinophilia in reslizumab clinical trials, high peripheral blood eosinophil levels are associated with low FEV1 reversibility

by J. Christian Virchow, Lisa Hickey, Evelyn Du, Margaret Garin
Published 2020-04-01

Reslizumab as add-on therapy in patients with refractory asthma

by J Christian Virchow, Mirna McDonald, Margaret Garin, Stephanie Korn
Published 2020-05-01